glp-1 monthly First 90 Days on Therapy: What to Expect Guide GLP-1 Medications Infographic | Medidex

Can GLP-1 receptor agonists lower blood pressure or cause hypotension

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

Its beneficial effects are attributed to its "gingeroids," a group of phenolic compounds that include gingerols and shogaols, responsible for ginger's pungent taste and therapeutic propertiesGinfort features the highest concentration of gingeroids on the market (26%), extracted solvent-free, with clinically proven efficacy in alleviating dyspepsia symptoms.Digestive Support for GLP-1 Treatments: GLP-1 agonists frequently cause digestive side effects, with nausea occurring in 40% of cases, vomiting in 25%, and bowel disturbances in 23%, often leading to treatment discontinuation (Sun F et al., Diabetes Technology & Therapeutics, 2015)

This begs the question:

Additionally, novel diagnostic tools, such as corneal confocal microscopy and biomarker-based tests, have improved early detection and intervention

Understanding what causes it and how to manage symptoms helps many people successfully continue treatment